ProMED’s Marjorie Pollack Interviewed about COVID-19 on the Oliver Wyman Forum
March 10, 2020
Identifying an emerging disease outbreak against the background noise of ongoing infections is a difficult task. ProMED's Deputy Editor, Marjorie Pollack, has done it - twice. Her role in alerting the international community to COVID-19 is captured in this recent interview.
You’re invited to join us for our latest webinar “#COVID19 #Vaccinology Update - Development, Use, and Effect on Public Health” available now on #IKEEP! @ShabirMadh @GMalavige
https://exchange.isid.org/isid/2021/covid-19-vaccinology-development-use-and-effect/314023/neelika.malavige.26.shabir.a.madhi.covid-19.vaccinology.development.use.and.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D1%2Ace_id%3D1950
New #IJID Editorial: "COVID-19 vaccines under the International Health Regulations – we must use the WHO International Certificate of Vaccination or Prophylaxis" #COVID19 #vaccination #COVIDvaccines @IDAdvance @WHO https://www.ijidonline.com/article/S1201-9712(21)00050-3/fulltext
In under-resourced countries, neonatal sepsis and post-partum endometritis continue to cause substantial morbidity and mortality, in both hospital and community settings. Read more in our #Guide to #InfectionControl in the Healthcare Setting! https://isid.org/guide/infectionprevention/infection-control-in-obstetrics/
Dalbavancin: novel candidate for #COVID19 treatment by inhibiting S-protein-ACE2 interaction. Promising studies in cell culture and animal studies, but potential limitations requiring further elucidation @ProMED_mail @ISID_org https://www.nature.com/articles/s41422-020-00459-5
You can still support ISID! Check out our Year-in-Review graphic that showcases all of the great work that the ISID community has led over the past year. Only with your generous support can we continue to do all of this and more in 2021.
https://isid.networkforgood.com
